Oral verrucous carcinoma arising from lichen planus and esophageal squamous cell carcinoma in a patient with hepatitis C virus-related liver cirrhosis-hyperinsulinemia and malignant transformation: A case report

Nagao,Yumiko; Sata,Michio

doi:10.3892/br.2012.14

Oral verrucous carcinoma arising from lichen planus and esophageal squamous cell carcinoma in a patient with hepatitis C virus-related liver cirrhosis-hyperinsulinemia and malignant transformation: A case report

Authors:
- Yumiko Nagao
- Michio Sata
View Affiliations

Affiliations: Department of Digestive Disease Information and Research, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
Published online on: October 3, 2012 https://doi.org/10.3892/br.2012.14
Pages: 53-56

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oral lichen planus (OLP) is a potentially malignant disorder associated with an increased risk of oral cancer. In Japan, the association of OLP with hepatitis C virus (HCV) infection is well documented. In the present study, a case of oral verrucous carcinoma arising from OLP coexisting vulvo‑vaginal‑gingival syndrome and esophageal squamous cell carcinoma (SCC) in a patient with HCV‑related liver cirrhosis is reported. A 71‑year old, non‑smoking Japanese woman presented with lesions of OLP affecting the bilateral buccal mucosa, tongue, gingival, palate, oral floor and lower lip. Ten years later, an exophytic mass developed in the mandibular alveolar mucosa, the right buccal mucosa and the right lower lip. Pathological diagnosis confirmed the presence of verrucous carcinoma. However, she developed esophageal rather than oral cancer. The oral cancer was resected surgically three times and the patients underwent radiotherapy. The esophageal cancer was removed by endoscopic submucosal dissection. The risk of carcinogenesis increased as hyperinsulinemia continued. The results suggested that it is necessary to monitor for malignant changes in patients with OLP lesions and HCV infection. In addition, treatment requires the cooperation of various medical specialists, as well as an oral surgeon.

View Figures

View References

1.	Eisen D: The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 88:431–436. 1999. View Article : Google Scholar : PubMed/NCBI
2.	Le Cleach L and Chosidow O: Clinical practice. Lichen planus. N Engl J Med. 366:723–732. 2012.
3.	Pelisse M, Leibowitch M, Sedel D and Hewitt J: A new vulvovaginogingival syndrome. Plurimucous erosive lichen planus. Ann Dermatol Venereol. 109:797–798. 1982.(In French).
4.	Warnakulasuriya S, Johnson NW and van der Waal I: Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 36:575–580. 2007. View Article : Google Scholar : PubMed/NCBI
5.	Gandolfo S, Richiardi L, Carrozzo M, et al: Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol. 40:77–83. 2004. View Article : Google Scholar : PubMed/NCBI
6.	Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB and Thongprasom K: Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 100:164–178. 2005. View Article : Google Scholar : PubMed/NCBI
7.	Gonzalez-Moles MA, Scully C and Gil-Montoya JA: Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 14:229–243. 2008. View Article : Google Scholar
8.	Bermejo-Fenoll A, Sánchez-Siles M, López-Jornet P, Camacho-Alonso F and Salazar-Sánchez N: A retrospective clinicopathological study of 550 patients with oral lichen planus in south-eastern Spain. J Oral Pathol Med. 39:491–496. 2010. View Article : Google Scholar : PubMed/NCBI
9.	Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E and Møller H: Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 40:677–683. 2011.
10.	Bombeccari GP, Guzzi G, Tettamanti M, Giannì AB, Baj A, Pallotti F and Spadari F: Oral lichen planus and malignant transformation: a longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 112:328–334. 2011. View Article : Google Scholar : PubMed/NCBI
11.	Nagao Y, Sata M, Tanikawa K, Itoh K and Kameyama T: Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest. 25:910–914. 1995. View Article : Google Scholar : PubMed/NCBI
12.	Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Demarosi F and Carrassi A: Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol. 151:1172–1181. 2004. View Article : Google Scholar : PubMed/NCBI
13.	Shengyuan L, Songpo Y, Wen W, Wenjing T, Haitao Z and Binyou W: Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis. Arch Dermatol. 145:1040–1047. 2009.PubMed/NCBI
14.	Lodi G, Pellicano R and Carrozzo M: Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis. 16:601–612. 2010. View Article : Google Scholar : PubMed/NCBI
15.	Petti S, Rabiei M, De Luca M and Scully C: The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology. 99:168–178. 2011. View Article : Google Scholar : PubMed/NCBI
16.	Nagao Y, Sata M, Tanikawa K, Itoh K and Kameyama T: High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med. 24:354–360. 1995. View Article : Google Scholar : PubMed/NCBI
17.	Nagao Y, Sata M, Itoh K, et al: High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma. Hepatol Res. 7:206–212. 1997.
18.	Nobles J, Wold C, Fazekas-May M, Gilbert J and Friedlander PL: Prevalence and epidemiology of hepatitis C virus in patients with squamous cell carcinoma of the head and neck. Laryngoscope. 114:2119–2122. 2004. View Article : Google Scholar : PubMed/NCBI
19.	Hunt J, Hagan J, Nobles J, Wold C, Fazekas-May M, Gilbert J and Friedlander PL: Outcome analysis of patients with squamous cell carcinoma of the head and neck and hepatitis C virus. Laryngoscope. 115:1882–1886. 2005. View Article : Google Scholar : PubMed/NCBI
20.	Yoshida M, Nagao Y, Sata M, Kusukawa J and Kameyama T: Multiple primary neoplasms and hepatitis C virus infection in oral cancer patients. Hepatol Res. 9:75–81. 1997. View Article : Google Scholar
21.	Nagao Y and Sata M: High incidence of multiple primary carcinomas in HCV-infected patients with oral squamous cell carcinoma. Med Sci Monit. 15:CR453–CR459. 2009.PubMed/NCBI
22.	Carrozzo M, Carbone M, Gandolfo S, Valente G, Colombatto P and Ghisetti V: An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Oral Oncol. 33:220–225. 1997. View Article : Google Scholar : PubMed/NCBI
23.	Spiro RH: Verrucous carcinoma, then and now. Am J Surg. 176:393–397. 1998. View Article : Google Scholar : PubMed/NCBI
24.	Sikuler E, Shnaider A, Zilberman D, Hilzenrat N, Shemer-Avni Y, Neumann L and Buskila D: Hepatitis C virus infection and extrahepatic malignancies. J Clin Gastroenterol. 24:87–89. 1997. View Article : Google Scholar : PubMed/NCBI
25.	Lee MH, Yang HI, Lu SN, et al: Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 206:469–477. 2012. View Article : Google Scholar : PubMed/NCBI
26.	Nagao Y, Kawaguchi T, Tanaka K, Kumashiro R and Sata M: Extrahepatic manifestations and insulin resistance in an HCV hyperendemic area. Int J Mol Med. 16:291–296. 2005.PubMed/NCBI
27.	Nagao Y, Kawasaki K and Sata M: Insulin resistance and lichen planus in patients with HCV-infectious liver diseases. J Gastroenterol Hepatol. 23:580–585. 2008. View Article : Google Scholar : PubMed/NCBI
28.	Jee SH, Ohrr H, Sull JW, Yun JE, Ji M and Samet JM: Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 293:194–202. 2005. View Article : Google Scholar
29.	Kawaguchi T and Sata M: Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization. World J Gastroenterol. 28:1943–1952. 2010. View Article : Google Scholar : PubMed/NCBI
30.	Nagao Y, Tomonari R, Kage M, Komai K, Tsubone K, Kamura T and Sata M: The possible intraspousal transmission of HCV in terms of lichen planus. Int J Mol Med. 10:569–573. 2002.PubMed/NCBI